Pylarify f-18 injections
Active Awarded Last action
- Contract number
- 36C24626A0027
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 6
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 1 $1,212,530 obligated
Award facts
- Opportunity
-
- 36C24626Q0649 Solicitation number
- Combined order value
- $1,212,530 Current and potential, with all options
- Last date to order 19% complete
- IDV ceiling 27% used
- $4,503,682.52
- Maximum order
- $30.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
Veterans Integrated Service Network 6 established a Blanket Purchase Agreement with Progenics Pharmaceuticals Inc. on August 20, 2026, with a ceiling of $4,503,682.52 and ultimate completion date of August 19, 2027, against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) for supply of PYLARIFY F-18 injections.
PYLARIFY (piflufolastat F-18) is a radiopharmaceutical diagnostic imaging agent used in positron emission tomography scans for prostate cancer detection. Performance occurs at Bedford, Massachusetts. Progenics Pharmaceuticals Inc. is a division of Lantheus Medical Imaging, Inc., a subsidiary of Lantheus Holdings, Inc., and manufactures and distributes PYLARIFY as the sole authorized supplier of this diagnostic product to federal healthcare providers.
A BPA call was issued on August 20, 2026, under this agreement with a ceiling value of $4,503,682.56 and firm fixed-price terms, with completion scheduled for August 19, 2027.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Pylarify f-18 injections | Veterans Integrated Service Network 6 (VHA) | $1,212,530 |
Quick answers
Who was awarded contract 36C24626A0027?
36C24626A0027 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 6 (Veterans Health Administration) on August 20, 2026.
How much is contract 36C24626A0027 worth?
Orders under 36C24626A0027 have obligated $1,212,530. 36C24626A0027's own ceiling is $4,503,683. A single order can be worth up to $30.
How many orders have been placed under contract 36C24626A0027?
1 order has been placed under 36C24626A0027, the latest on August 20, 2026.
Who can order from contract 36C24626A0027?
36C24626A0027 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36C24626A0027 under another contract?
Yes. 36C24626A0027 is a blanket purchase agreement under 36F79725D0093, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24626A0027 competed?
The extent of competition for 36C24626A0027 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV